Picture of Johnson & Johnson logo

JNJ — Johnson & Johnson News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

China approves J&J's oral psoriasis pill, says drugmaker

China approves J&J's oral psoriasis pill, says drugmaker

- Johnson & Johnson JNJ.N said on Thursday that its oral drug icotrokinra was approved in China for moderate-to-severe plaque psoriasis.


(Reporting by Andrew Silver in Shanghai
Editing by Tomasz Janowski)

((andrew.silver@thomsonreuters.com))

Recent news on Johnson & Johnson

See all news